001). Conclusion: We identified a subgroup of patients who had MHN/SMHN from HBV related cirrhotic patients. They had extensive hepatic necrotic area, more obvious ductular regeneration, more severe cholestasis and were more easily complicated with sepsis. Key Word(s): 1. Cirrhosis; 2. Pathology; 3. Necrosis; Presenting Author: GUOCHAO NIU Additional Authors: XIAOLAN ZHANG Corresponding Author: XIAOLAN ZHANG Affiliations: The Second Hospital of Hebei Medical University Objective: Hepatobiliary disorders are frequently encountered

Buparlisib cell line in inflammatory bowel disease. Lipopolysaccharide (LPS)/Toll receptor 4 (TLR4) signaling pathway plays a pivotal role in the pathogenesis

of various chronic liver diseases. Mesenchymal selleck compound stem cells (MSCs) is an important means for the treatment of liver diseases This study investigated the protective role and mechanism of MSCs in the hepatobiliary disorders. Methods: Chronic colitis was induced by administration of dextran sodium sulfate (DSS) drinking water. Mice were grouped as follows: DSS+Vehicle group, DSS + MSCs group and control group. Severity of colitis was evaluated by body weight (BW), disease activity index (DAI), colon length, colon histology changes and pathology score. The histopathology changes of liver were determined correspondingly. The liver function test, serum levels of LPS and bacterial translocation of mesenteric lymph nodes were detected. The expressions of protein and mRNA of TNF-α, IFN-γ, IL-1β, IL-17A, TLR4, TRAF6, and NF-KB in liver were detected by immunohistochemistry, western blot and real-time Q-PCR, respectively. Results: The results

of BW, DAI, colon length and histological assessment of colon and liver revealed that in DSS + Vehicle group, the more severe colitis the mice showed, the more severe hepatobiliary disorders were showed. Inflammatory cell infiltrated into the bile duct, hepatocyte degeneration in DSS + Vehicle group, which was alleviated after the treatment of MSCs (P < 0.05). Abnormal liver function in DSS + Vehicle group was showed, while was significantly ameliorated after treatment (P < 0.05). The levels of serum LPS Isotretinoin and bacterial translocation remarkedly increased in DSS + Vehicle group, however they significantly lowered after treatment. The protein and mRNA levels of TNF-α, IFN-γ, IL-1β, IL-17A, TLR4, TRAF6 and NF-κB significantly increased in DSS + Vehicle group and down-regulated in DSS + MSCs group (P < 0.05). Conclusion: Our results reveal that MSCs may be a novel therapeutic drug for the treatment of chronic colitis-associated hepatobiliary disorders, which correlated to downregulating the LPS/TLR4 signaling pathway. Key Word(s): 1. MSCs; 2. chronic colitis; 3. hepatobiliary; 4.